Article Details

Biohaven's Nurtec ODT outmuscles AbbVie's Ubrelvy in gaining new migraine patients following ...

Retrieved on: 2021-08-09 16:27:38

Tags for this article:

Click the tags to see associated articles and topics

Biohaven's Nurtec ODT outmuscles AbbVie's Ubrelvy in gaining new migraine patients following .... View article details on hiswai:

Excerpt

... with their over competing triptans and injectable monoclonal antibodies, like Amgen's Aimovig, Eli Lilly's Emgality and Teva Pharmaceuticals' Ajovy.

Article found on: www.fiercepharma.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up